Compounds > doxifluridine
Page last updated: 2024-08-22

doxifluridine and Invasiveness, Neoplasm

doxifluridine has been researched along with Invasiveness, Neoplasm in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (35.71)18.2507
2000's8 (57.14)29.6817
2010's1 (7.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hwang, SH; Kim, SG1
Asaumi, Y; Hara, T; Hirano, M; Kikkawa, H; Kikuchi, T; Murakami, N; Nozawa, H; Takizawa, M; Uno, Y1
Sakaguchi, K; Tsuchie, K; Yoneyama, F1
Ikeda, S; Ishibashi, N; Matono, K; Mizobe, T; Ogata, Y; Ogo, S; Ohkita, A; Ozasa, H; Sasatomi, T; Shirouzu, K1
Fujio, N; Fukuda, Y; Ihara, T; Koyama, I; Osugi, H; Takatori, H; Tsukazaki, T; Tsukazaki, Y1
Akagi, Y; Ikeda, S; Ishibashi, N; Matono, K; Mizobe, T; Mori, S; Murakami, H; Ogata, Y; Ozasa, H; Shirouzu, K1
Horichi, H; Kumaki, T; Matsuki, N; Shima, K; Tajima, H; Takeda, T1
Hirayama, R; Kojima, K; Mishima, Y; Nakamura, T; Nihei, Z; Shirota, Y; Tohyama, Y; Yasuda, S1
Hoshino, K; Ikeda, H; Kamoshita, N; Kobayashi, J; Koyama, T; Morishita, Y; Nakamura, M; Tanaka, T1
Asano, K; Fujita, H; Izumi, R; Kanno, M; Kojima, Y; Konishi, K; Matsuki, N; Miyata, R; Miyazaki, I; Mura, T; Nishimura, G; Ooto, T; Sasaki, T; Sawa, T; Syouji, M; Takada, M; Takeyama, S; Takigawa, Y; Takita, Y; Ueda, H; Ueno, K; Yamazaki, H1
Fujii, H; Kumagai, K; Terai, Y; Ueda, M; Ueki, K; Ueki, M; Yanagihara, T; Yoshizawa, K1
Hayashida, H; Higuchi, K; Okada, Y; Soga, H; Yoshiki, T1
Kimura, T; Kobayashi, T1
Baldwin, SA; Cass, CE; Clarke, ML; Coupland, RW; Dabbagh, L; Jennings, LL; Koski, SL; Mackey, JR; Santos, CL; Vsianska, M; Young, JD1

Trials

1 trial(s) available for doxifluridine and Invasiveness, Neoplasm

ArticleYear
[Long-term outcome of preoperative chemotherapy with 5'-deoxy-5-fluorouridine (5'-DFUR) for gastric cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:10

    Topics: Administration, Oral; Aged; Antineoplastic Agents; Female; Floxuridine; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Stomach Neoplasms; Survival Rate; Treatment Outcome

2000

Other Studies

13 other study(ies) available for doxifluridine and Invasiveness, Neoplasm

ArticleYear
The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer.
    World journal of surgical oncology, 2016, Apr-02, Volume: 14

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Drug Combinations; Female; Floxuridine; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Tegafur; Time Factors; Uracil

2016
[A case of recurrent gastric cancer that responded dramatically to docetaxel and 5'-DFUR combination chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:9

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Floxuridine; Fluorouracil; Gastrectomy; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Pancreatic Neoplasms; Stomach Neoplasms; Taxoids; Treatment Outcome

2002
Massive mucinous carcinoma of the breast untreated for 6 years.
    International journal of clinical oncology, 2003, Volume: 8, Issue:2

    Topics: Adenocarcinoma, Mucinous; Biopsy, Needle; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Floxuridine; Follow-Up Studies; Humans; Immunohistochemistry; Mastectomy; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Skin Neoplasms; Skin Ulcer; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2003
The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
    Cancer chemotherapy and pharmacology, 2006, Volume: 57, Issue:5

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Floxuridine; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Period; Retrospective Studies; Survival Rate; Tegafur; Uracil

2006
[A case of advanced gastric cancer with direct invasion of the transverse colon responding to paclitaxel/5'-DFUR combined therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:12

    Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Colon, Transverse; Colonic Neoplasms; Drug Administration Schedule; Floxuridine; Humans; Ileus; Male; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Peritoneal Neoplasms; Quality of Life; Stomach Neoplasms

2005
The expression of vascular endothelial growth factor determines the efficacy of post-operative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
    Oncology reports, 2006, Volume: 15, Issue:5

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Floxuridine; Humans; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Period; Retrospective Studies; Survival Rate; Tegafur; Vascular Endothelial Growth Factor A

2006
[A case of cutaneous and brain metastasis of gastric carcinoma, treated effectively by chemotherapy with CDDP, MMC, etoposide and 5'-DFUR].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:15

    Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Drug Administration Schedule; Etoposide; Female; Floxuridine; Humans; Infusions, Intravenous; Mitomycin; Neoplasm Invasiveness; Skin Neoplasms; Stomach Neoplasms; Treatment Outcome

1994
[A case of nonresectable advanced gastric cancer responding to combined chemotherapy with 5'-DFUR, CDDP, and MMC].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Floxuridine; Humans; Male; Mitomycin; Neoplasm Invasiveness; Stomach Neoplasms

1996
[Unresectable gastric cancer followed by remarkably effective tumor disappearance and good quality of life for 10 months after CDDP/5'-DFUR combination chemotherapy--a case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:13

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Esophageal Neoplasms; Female; Floxuridine; Humans; Infusions, Intravenous; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Invasiveness; Quality of Life; Stomach Neoplasms

1996
[Effect on 5'-deoxy-5-fluorouridine (5'-DFUR) of pyrimidine nucleoside phosphorylase (PyNPase), matrix metalloprotease and serum IAP values. Hokuriku Colorectal Cancer Chemotherapy Study Group].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:13

    Topics: Adult; Aged; Antineoplastic Agents; Colonic Neoplasms; Extracellular Matrix; Female; Floxuridine; Humans; Lymphatic Metastasis; Male; Metalloendopeptidases; Middle Aged; Neoplasm Invasiveness; Neoplasm Proteins; Pentosyltransferases; Pyrimidine Phosphorylases; Rectal Neoplasms

1997
Effects of sex steroids and growth factors on invasive activity and 5'-deoxy-5-fluorouridine sensitivity in ovarian adenocarcinoma OMC-3 cells.
    Japanese journal of cancer research : Gann, 1998, Volume: 89, Issue:12

    Topics: Basement Membrane; Cell Division; Cell Movement; Collagenases; Culture Media, Conditioned; Cystadenocarcinoma, Mucinous; Drug Resistance, Neoplasm; Enzyme Induction; Epidermal Growth Factor; ErbB Receptors; Estradiol; Female; Fibronectins; Floxuridine; Humans; Matrix Metalloproteinase 3; Neoplasm Invasiveness; Neoplasm Proteins; Ovarian Neoplasms; Prodrugs; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Thymidine Phosphorylase; Transforming Growth Factor alpha; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator

1998
[Case report of a patient with invading bladder cancer and lymph node swelling which decreased following 5'-DFUR treatment].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:2

    Topics: Aged; Antineoplastic Agents; Child, Preschool; Floxuridine; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Invasiveness; Urinary Bladder Neoplasms

2000
Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:1

    Topics: Affinity Labels; Animals; Antibodies, Monoclonal; Antibody Formation; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Deoxycytidine; Drug Resistance, Neoplasm; Equilibrative Nucleoside Transporter 1; Female; Floxuridine; Fluorouracil; Humans; Immunoenzyme Techniques; Membrane Transport Proteins; Mice; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasm Staging; Thioinosine

2002